Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 64 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Apotheek Gevaert from Waregem, company number BE0820832410, closed financial year 2025 with a result of € 30,345 after tax. For that financial year Apotheek Gevaert recorded a gross margin of € 134,094 and equity of € 701,333. Compared with financial year 2024, the result moved from € -3,884 to € 30,345. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 19, 2026.
€ 701,333
▲ 160% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 30,345
▲ still € 3,884 loss in 2024
Profit after tax over the fiscal year.
€ 184,016
▲ 142% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 177,483.
People and assets in 2025
0.4
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 37,975
▲ € 32,977 vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 99,248
▲ 38% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,804
▲ € 2,201 vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 142,631 | € 131,031 | € 53,241 | € 134,094 | ▲ 152% |
| Profit after taxes | € 39,229 | € 40,112 | € -3,884 | € 30,345 | ▲ € 34,229 |
| Equity | € 233,310 | € 273,422 | € 269,538 | € 701,333 | ▲ 160% |
| Total debts | € 178,310 | € 99,340 | € 256,287 | € 1,073,137 | ▲ € 816,850 |
| Cash | € 52,745 | € 47,743 | € 76,042 | € 184,016 | ▲ 142% |
| Land & buildings | € 181,501 | € 142,371 | € 103,577 | € 1,020,923 | ▲ € 917,346 |
| Retained profit | € 110,910 | € 151,022 | € 147,138 | € 177,483 | ▲ 21% |
| Dividend | € 800 | € 0 | € 0 | € 0 | |
| Bank debt | € 2,622 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 411,620 | € 372,762 | € 525,825 | € 1,774,470 | ▲ 237% |
| Employees (FTE) | 1 | 0.8 | 0.3 | 0.4 | ▲ 0.1 |
Key figures of Apotheek Gevaert, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Gevaert?
What happened at Apotheek Gevaert in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 30,345. Source: NBB ↗
- Johan T'Jollyn stepped down as director. NBB
- Johan T'Jollyn became a director. NBB
- New establishment in Waregem. KBO
- Start of the company according to the CBE. KBO
In short
From € 39,229 profit in 2022 to € 30,345 profit in 2025.
Paid € 22,377 in corporate taxes since 2022.
Best year ever: 2023, with € 40,112 profit.
On average € 142,600 of value added per employee in 2022.
A new publication or filing at Apotheek Gevaert? We notify you, reason included.
Follow Apotheek GevaertDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Sté comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek GevaertBehind Apotheek Gevaert is Sté BV. The shares are held by Sté (100%).
Directors
According to the 2025 annual accounts
Director · represented by Stéphanie Gevaert
Also active at: Apotheek Cnudde, Stéphanie GEVAERT
Johan T'Jollyn
Director
since 2023 · until 2025
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Vijfseweg 134
8790 Waregem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0820.832.410
- VAT number
- BE 0820.832.410
- Registered office
- Vijfseweg 134, 8790 Waregem
- Names & denominations
- Apotheek Gevaert
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 November 2009
- Peppol
- Active · Active since 15 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten